Hepatic Iron Contents and Response to Interferon-α in Patients with Chronic Hepatitis C: Relationship to Genotypes of Hepatitis C Virus

Digestive Diseases and Sciences

Volumn 41, Issue 5, 1996, Pages 989-994

  Izumi, Namiki ^b   Enomoto, Nobuyuki ^b   Uchihara, Masakatsu ^b   Murakami, Takeshi ^b   Ono, Keiichi ^b   Noguchi, Osamu ^b   Miyake, Shozo ^b   Nouchi, Toshihiko ^b   Fujisawa, Kiyoshi ^b   Marumo, Fumiaki ^b   Sato, Chifumi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NONE

Author keywords

Chronic hepatitis; Hepatitis C virus; Interferon ; Iron

Indexed keywords

IRON; RECOMBINANT ALPHA2B INTERFERON; VIRUS RNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VIRUS GENOME;

ADOLESCENT; ADULT; ALCOHOL DRINKING; BIOPSY, NEEDLE; CHRONIC DISEASE; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON ALFA-2B; IRON; LIVER; MALE; MENOPAUSE; MIDDLE AGED; REMISSION INDUCTION; RNA, VIRAL;

EID: 0029876211     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02091542     Document Type: Article

References (25)

1. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HJ, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, van Thiel DH, Tamburro C, Lefkowitch J, Albrecht J, Meschievitz C, Ortego TJ, Gibas A, Hepatitis Interventional Therapy Group: Treatment of chronic hepatitis C with recombinant interferon alpha. A multicenter randomized, controlled trial. N Engl J Med 321:1501-1506, 1989
2. Hino K, Sainokami S, Shimoda K, Iino S, Wang Y, Okamoto H, Miyakawa Y, Mayumi M: Genotype and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. J Med Virol 42:299-305, 1994
3. Tsubota A, Chayama K, Ikeda K, Yasuji A, Koida I, Saitoh S, Hashimoto M, Iwasaki S, Kohayashi M, Hiromitsu K: Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection. Hepatology 19:1088-1094, 1994
4. Van Thiel DH, Friedlander L, Fagiuoli S, Wright III, Irish W, Gavaler JS: Response to interferon therapy is influenced by the iron content of the liver. J Hepatol 20:410-415, 1994
5. Clemente MG, Congia M, Lai ME, Lilliu F, Lampis R, Frau F, Frau MR, Faa G, Diana G, Dessi C, Melis A, Mazzoleni AP, Cornacchia G, Cao A, De Virgillis S: Effect of iron overload on the response to recombinant interferon-alpha treatment in transfusion-dependent patients with thalassemia major and chronic hepatitis C. J Pediatr 125:123-128, 1994
6. Bacon BR, Tavill AS: Role of the liver in normal iron metabolism. Semin Liver Dis 4:181-192, 1984
7. Weinberg ED: Iron in neoplastic disease. Cancer 4:223-233, 1983
8. Jacobs A: Low molecular weight intracellular iron transport compounds. Blood 439, 1977
9. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer F: Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 19:1513-1520, 1994
10. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, Mayumi M: Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 73:673-679, 1992
11. Kato N, Yokosuka O, Hosoda K, Ito Y, Ohto M, Omata M: Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction; increase of the virus in advanced liver disease. Hepatology 18:16-20, 1993
12. Isomura T, Yano M, Hayashi H, Sakamoto N: Excess iron in the liver of patients with chronic hepatitis C. J Clin Electron Microsc 25:231-237, 1992
13. Wonke B, Hoffbrand AV, Brown D, Dusheiko G: Antibody to hepatitis C virus in multiply transfused patients with thalassemia major. J Clin Pathol 43:638-640, 1990
14. Nemser HS, Hammerman HS: Hemochromatosis, chondrocalcinosis, and hepatitis C. Hosp Pract 26:51-52, 1991
15. Hayashi H, Takikawa T, Nishimura N, Yano M, Isomura T, Sakamoto N: Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron. Am J Gastroenterol 89:986-988, 1994
16. Piperno A, Fargion S, D'Alba R, Roffi L, Fracanzani AL, Vecchi L, Failla M, Fiorelli G: Liver damage in Italian patients with hereditary hemochromatosis is highly influenced by hepatitis B and C virus infection. J Hepatol 16:364-368, 1992
17. Rocchi E, Cassanelli M, Borghi A, Paolillo F, Pradelli M, Casalgrandi G, Burani A, Gallo E: Magnetic resonance imaging and different levels of iron overload in chronic liver disease. Hepatology 17:997-1002, 1993
18. IS. Girelli CM, Mirata C, Lesinigo E: Iron overload and response to α-interferon in chronic hepatitis C. Am J Gastroenterol 90:170-171, 1995
19. Caraceni P, Fagiuoli S: Iron reduction therapy: Simply camouflage, or a real weapon? Am J Gaslroenterol 89:970-972, 1994
20. Di Bisceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR: Measurements of iron status in patients with chronic hepatitis. Gastroenterology 102:2108-2113, 1992
21. Lau JYN, Davis GL, Kniffen J, Qian KP, Urdea MS, Chan CS, Mizokami M, Neuwald PD, Wilber JC: Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet, 341:1501-1504, 1993
22. Koizumi K, Enomoto N, Kurosaki M, Murakami T, Izumi N, Marumo F, Sato C: Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment. Hepatology 22:30-35, 1995
23. Good MF, Powell LW, Halliday JW: Iron status and cellular immune competence. Blood Rev 2:43-49, 1988
24. Keown P, Descamps-Latscha B: In vitro suppression of cell-mediated immunity by feroproteins and ferric salts. Cell Immunol 80:257-266, 1983
25. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Izumi N, Marumo F, Sato C: Comparison of full-length sequences of interferon sensitive and resistant hepatitis C virus 1b: Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J Clin Invest 96:224-230, 1995